Creative Planning »

Enliven Therapeutics shares owned by Creative Planning

Quarter-by-quarter ownership of Enliven Therapeutics (ELVN) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Enliven Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Enliven Therapeutics held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enliven Therapeutics by Creative Planning

Quarter filed Position value Share count Share price at filing
2026-03-31 $536k 14k 39.20

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Index Shs Fds State Street Spd (SPDW)
Spdr Series Trust State Street Spd (SPMD)
Ishares Core Msci Emkt (IEMG)
Vanguard Index Fds Large Cap Etf (VV)
Apple (AAPL)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Series Trust State Street Spd (SPYM)
Vanguard Index Fds Mid Cap Etf (VO)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for Creative Planning

Top funds holding Enliven Therapeutics

OrbiMed Advisors
FMR
BlackRock
Polar Capital Holdings
Commodore Capital
Vestal Point Capital
Vanguard Group
Citadel Advisors
Fairmount Funds Management
VR Adviser
Novo A/S
Geode Capital Management
State Street Corporation
Logos Global Management
Pictet Asset Management Holding SA

View all funds holding Enliven Therapeutics